At 19.1x earnings and just 13.1x forward earnings, the market is pricing KRT as a no-growth cyclical despite a 16.70% ROIC and a pristine Altman Z-Score of 4. The balance sheet signals low bankruptcy risk, and the compression from trailing P/E to forward P/E implies earnings expansion the market is not fully rewarding. A 1.3x Price/Sales multiple for a company producing 20.60% operating margins is not expensive in absolute terms, especially with a solid Piotroski F-Score of 6. This looks like a financially stable small-cap trading at a muted growth multiple, suggesting modest mispricing to the upside rather than deep distress.
⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.